The Study of the Influence of Unfolded Protein Response and Autophagy on Sorafenib-Induced Tumor Inhibition of Hepatocellular Carcinoma
Accepted Date: Mar 21, 2022 / Published Date: Mar 28, 2022
Abstract
To study the effects of the unfolded protein response (UPR) activation and autophagy inhibition on sorafenib inducing apoptosis of hepatocellular carcinoma (HCC) cells. We activated UPR of the HepG2 cells by dithiothreitol (DTT) and tunicamycin (Tun). 3-methyladenine was used to inhibit autophagy of HepG2 cells. The proliferation, apoptosis and adhesion ability of HCC cells were tested by MTT assay and flow cytometry, respectively. The invasion and migration abilities of cells were detected by Trans well assay. Moreover, we established HCC orthotopic transplantation tumor model of nude mice. The activation of UPR can inhibit the sorafenib-induced apoptosis of HCC cells. Inhibiting autophagy significantly enhanced the sorafenib-induced apoptosis of HCC cells. Activating the UPR can enhance the sorafenib resistance of HCC cells. On the contrary, inhibiting autophagy causes opposite effects.
Citation: Wu J, Zhuang Q, Gao X, Yang X, Qin R, et al. (2022) The Study of the Influence of Unfolded Protein Response and Autophagy on Sorafenib-Induced Tumor Inhibition of Hepatocellular Carcinoma. Cell Mol Biol, 68: 227. Doi: 10.4172/1165-158X.1000227
Copyright: © 2022 Wu J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 3215
- [From(publication date): 0-2022 - Dec 21, 2024]
- Breakdown by view type
- HTML page views: 2780
- PDF downloads: 435